Rosuvastatin in Patients with Elevated C-Reactive Protein Reply

被引：0
|
作者：
Ridker, Paul M. [1 ]
Glynn, Robert J. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 10期
关键词：
CLINICAL-TRIALS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1041 / 1042
页数：2
相关论文
共 50 条
  • [31] Bayesian Number-Needed-to-Treat Analysis of Rosuvastatin for Prevention of Venous Thromboembolism in Patients with Elevated High Sensitivity C-Reactive Protein
    Lang, Christopher
    Arora, Rohit
    [J]. CIRCULATION, 2010, 122 (21)
  • [32] Release of C-reactive protein by stenting - Reply
    Inoue, T
    Kato, T
    Uchida, T
    Sakuma, M
    Nakajima, A
    Shibazaki, M
    Imoto, Y
    Saito, M
    Hashimoto, S
    Hikichi, Y
    Node, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1734 - 1734
  • [33] SEPSIS PLUS C-REACTIVE PROTEIN - REPLY
    POURCYROUS, M
    BADA, HS
    KORONES, SB
    BASELSKI, V
    WONG, SP
    [J]. PEDIATRICS, 1994, 93 (04) : 694 - 694
  • [34] Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein
    MacDonald, Gary P.
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (08): : 427 - 436
  • [35] COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN
    MacDonald, G. P.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A163 - A163
  • [36] Procalcitonin or C-Reactive Protein: That Is the Question? Reply
    Nobre, Vandack
    Oliveira, Carolina Ferreira
    Alves Oliveira, Clara Rodrigues
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (04) : E311 - E312
  • [37] Vitamin C treatment reduces elevated C-reactive protein
    Block, Gladys
    Jensen, Christopher D.
    Dalvi, Tapashi B.
    Norkus, Edward P.
    Hudes, Mark
    Crawford, Patricia B.
    Holland, Nina
    Fung, Ellen B.
    Schumacher, Laurie
    Harmatz, Paul
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (01) : 70 - 77
  • [38] Ezetimibe added to rosuvastatin for severely hypercholesterolemic patients: Effects on lipid measures and C-reactive protein
    Ose, L
    Tonstad, S
    Harris, S
    Marotti, M
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 117 - 117
  • [39] Evaluation of the ezetimibe/simvastatin tablet compared with atorvastatin or rosuvastatin on C-reactive protein in patients with hypercholesterolemia
    Catapano, A. L.
    Ballantyne, C. M.
    Abate, N.
    Davidson, M. H.
    Brady, W. E.
    Gazzara, R. A.
    Tershakovec, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 555 - 555
  • [40] Elevated C-reactive protein and maintenance of atrial fibrillation
    Kumagai, K
    Nakashima, H
    Saku, K
    [J]. CLINICAL CARDIAC PACING AND ELECTROPHYSIOLOGY, 2003, : 427 - 432
12345